Abstract
Summary
Calcium supplements appear to increase cardiovascular risk, but the mechanism is unknown. We investigated the acute effects of calcium supplements on blood pressure in postmenopausal women. The reduction in systolic blood pressure was smaller after calcium compared with the placebo in the hours following dosing.
Introduction
Calcium supplements appear to be associated with increased cardiovascular risk; however, the mechanism of this is uncertain. We previously reported that blood pressure declined over a day in older women, and that this reduction was smaller following a calcium supplement. To confirm this finding, we investigated the acute effects of calcium supplements on blood pressure.
Methods
This was a randomised controlled crossover trial in 40 healthy postmenopausal women (mean age 71 years and BMI 27.2 kg/m2). Women attended on two occasions, with visits separated by ≥7 days. At each visit, they received either 1 g of calcium as citrate, or placebo. Blood pressure and serum calcium concentrations were measured immediately before, and 2, 4 and 6 h after each intervention.
Results
Ionised and total calcium concentrations increased after calcium (p < 0.0001 versus placebo). Systolic blood pressure decreased after both calcium and placebo, but significantly less so after calcium (p = 0.02). The reduction in systolic blood pressure from baseline was smaller after calcium compared with placebo by 6 mmHg at 4 h (p = 0.036) and by 9 mmHg at 6 h (p = 0.002). The reduction in diastolic blood pressure was similar after calcium and placebo.
Conclusions
These findings are consistent with those of our previous trial and indicate that the use of calcium supplements in postmenopausal women attenuates the post-breakfast reduction in systolic blood pressure by around 6–9 mmHg. Whether these changes in blood pressure influence cardiovascular risk requires further study.
Similar content being viewed by others
References
Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, Reid IR (2015) Calcium intake and risk of fracture: systematic review. BMJ 351:h4580
Tai V, Leung W, Grey A, Reid IR, Bolland MJ (2015) Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ 351:h4183
Lewis JR, Zhu K, Prince RL (2012) Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res 27:719–722
Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683
Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, Gamble GD, Grey A, Reid IR (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336:262–266
Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691
Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040
Li K, Kaaks R, Linseisen J, Rohrmann S (2012) Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98:920–925
Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y (2013) Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 173:639–646
Pentti K, Tuppurainen MT, Honkanen R, Sandini L, Kroger H, Alhava E, Saarikoski S (2009) Use of calcium supplements and the risk of coronary heart disease in 52–62-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 63:73–78
Paik JM, Curhan GC, Sun Q, Rexrode KM, Manson JE, Rimm EB, Taylor EN (2014) Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int 25:2047–2056
Shah SM, Carey IM, Harris T, DeWilde S, Cook DG (2010) Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf 19:59–64
Michaelsson K, Melhus H, Warensjo Lemming E, Wolk A, Byberg L (2013) Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 346:f228
Bristow SM, Gamble GD, Stewart A, Horne L, House ME, Aati O, Mihov B, Horne AM, Reid IR (2014) Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr 112:1611–1620
Heaney RP, Dowell MS, Bierman J, Hale CA, Bendich A (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 20:239–246
Reid IR, Gamble GD, Bolland MJ (2016) Circulating calcium concentrations, vascular disease and mortality: a systematic review. J Intern Med
Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S (1988) Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297:960–963
Park S-H, Kim S-K, Bae Y-J (2012) Relationship between serum calcium and magnesium concentrations and metabolic syndrome diagnostic components in middle-aged Korean men. Biol Trace Elem Res 146:35–41
Fraser A, Williams D, Lawlor DA (2010) Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001–2006). PLoS One 5:e13882
Jorde R, Schirmer H, Njølstad I, Løchen M-L, Mathiesen EB, Kamycheva E, Enschau Y, Grimnes G (2013) Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol 28:569–578
Nilsson IL, Rastad J, Johansson K, Lind L (2001) Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 130:986–990
Kamycheva E, Jorde R, Haug E, Sager G, Sundsfjord J (2005) Effects of acute hypercalcaemia on blood pressure in subjects with and without parathyroid hormone secretion. Acta Physiol Scand 184:113–119
Bristow SM, Gamble GD, Stewart A, Horne AM, Reid IR (2015) Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br J Nutr 114:1868–1874
Angus RM, Sambrook PN, Pocock NA, Eisman JA (1989) A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc 89:209–214
Millar-Craig MW, Bishop CN, Raftery EB (1978) Circadian variation of blood-pressure. Lancet 1:795–797
Lipsitz LA, Fullerton KJ (1986) Postprandial blood pressure reduction in healthy elderly. J Am Geriatr Soc 34:267–270
Yaron M, Roach V, Izkhakov E, Ish-Shalom M, Sack J, Sofer Y, Azzam I, Ray A, Stern N, Tordjman KM (2014) Effects of a typical acute oral calcium load on arterial properties and endothelial function in healthy subjects. Eur J Clin Nutr 68:608–612
Burt MG, Mangelsdorf BL, Srivastava D, Petersons CJ (2013) Acute effect of calcium citrate on serum calcium and cardiovascular function. J Bone Miner Res 28:412–418
Law MR, Wald NJ, Morris JK, Jordan RE (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326:1427
Blood Pressure Lowering Treatment Trialists’ Collaboration (2000) Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 356:1955–1964
Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL (2002) Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens 15:111–118
Brotman DJ, Davidson MB, Boumitri M, Vidt DG (2008) Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens 21:92–97
Yano Y, Kario K (2012) Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertension Res 35:695–701
Van Mierlo LAJ, Arends LR, Streppel MT, Zeegers MPA, Kok FJ, Grobbee DE, Geleijnse JM (2006) Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 20:571–580
Griffith LE, Guyatt GH, Cook RJ, Bucher HC, Cook DJ (1999) The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens 12:84–92
Reid IR, Horne A, Mason B, Ames R, Bava U, Gamble GD (2005) Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab 90:3824–3829
Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA, Mason J (2006) Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev CD004639
Bristow SM, Gamble GD, Stewart A, Horne AM, Reid IR (2015) Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br J Nutr 1–7
Marone C, Beretta-Piccoli C, Weidmann P (1980) Role of haemodynamics, catecholamines and renin in acute hypercalcaemic hypertension in man. Clin Sci (Lond) 59(6):369s–371s
Cohn JN (1983) Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. Ann Intern Med 98:806–809
Smajilovic S, Tfelt-Hansen J (2007) Calcium acts as a first messenger through the calcium-sensing receptor in the cardiovascular system. Cardiovasc Res 75:457–467
Odenwald T, Nakagawa K, Hadtstein C, Roesch F, Gohlke P, Ritz E, Schaefer F, Schmitt CP (2006) Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J Am Soc Nephrol 17:655–662
Fryer RM, Segreti JA, Widomski DL, Franklin PH, Banfor PN, Koch KA, Nakane M, Wu-Wong JR, Cox BF, Reinhart GA (2007) Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcet. J Pharmacol Exp Ther 323:217–226
Bauer DC (2013) Clinical practice. Calcium supplements and fracture prevention. N Engl J Med 369:1537–1543
Visvanathan R, Horowitz M, Chapman I (2006) The hypotensive response to oral fat is comparable but slower compared with carbohydrate in healthy elderly subjects. Br J Nutr 95:340–345
Gentilcore D, Bryant B, Wishart JM, Morris HA, Horowitz M, Jones KL (2005) Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly. Am J Med 118:1289
Gonzalez JT, Stevenson EJ (2014) Calcium co-ingestion augments postprandial glucose-dependent insulinotropic peptide(1–42), glucagon-like peptide-1 and insulin concentrations in humans. Eur J Nutr 53:375–385
Soares M, Kuriyan R, Kurpad A (2010) Calcium and vitamin D modulate postprandial vascular function: a pilot dose response study. Diab Met Syn Clin Res Rev 4:128–131
Bristow SM, Gamble GD, Stewart A, Kalluru R, Horne AM, Reid IR (2015) Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial. Br J Nutr 113:1585–1594
Acknowledgments
This study was funded by the Health Research Council of New Zealand. EOB is a recipient of a Doctoral Scholarship from the University of Auckland and a Helios Scholarship from the University of Calgary. SMB is funded by an Auckland Medical Research Foundation Edith C. Coan Research Fellowship and a Kelliher Charitable Trust Emerging Research Start-Up Award. The funders had no role in the design of the study, analysis of the results or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Statement of human rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Emma O. Billington and Sarah M. Bristow are joint first authors.
Rights and permissions
About this article
Cite this article
Billington, E.O., Bristow, S.M., Gamble, G.D. et al. Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women. Osteoporos Int 28, 119–125 (2017). https://doi.org/10.1007/s00198-016-3744-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-016-3744-y